OTCMKTS:KHRNF Khiron Life Sciences (KHRNF) Stock Price, News & Analysis → Everybody laughed when he recommended Netflix (From Stansberry Research) (Ad) Free KHRNF Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range$0.0001▼$0.017552-Week Range N/AVolumeN/AAverage Volume172,809 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Khiron Life Sciences alerts: Email Address Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry About Khiron Life Sciences Stock (OTCMKTS:KHRNF)Khiron Life Sciences Corp. operates as an integrated medical and cannabis company in Latin America and Europe. It operates through Health Services, Medical Cannabis Products, and Wellbeing Products segments. The company focuses on the cultivation, production, distribution, and export of tetrahydrocannabinol and cannabidiol (CBD) medical cannabis. It also operates a network of health centers and satellite clinics under the ILANS and Zerenia brands; develops CBD-based cosmeceutical products under the Kuida brand name; and operates Zerenia clinic in Medellin and Peru. Khiron Life Sciences Corp. was incorporated in 2012 and is headquartered in Vancouver, Canada.Read More Ad Wall Street StarThis Apple-like Innovator is Revolutionizing HealthcareAI has infiltrated so many sectors, it's sent the demand for AI-friendly GPU computer chips rocketing. Nvidia has gone up more than 3x in the past year. It is now valued well over $2 trillion, making it one of the largest companies in the world.Click here to learn more about the booming eHealth industry KHRNF Stock News HeadlinesMay 16, 2024 | morningstar.comKhiron Life Sciences Corp KHRNFMay 1, 2024 | wsj.comKhiron Life Sciences Corp.February 19, 2024 | finance.yahoo.comKhiron Life Sciences Corp. (KHRNF)January 3, 2024 | benzinga.comKhiron Life Sciences Stock (OTC:KHRNF) Dividends: History, Yield and DatesNovember 17, 2023 | finance.yahoo.comKhiron Life Sciences Announces Closing of the Sale of Its European BusinessOctober 8, 2023 | finance.yahoo.comKhiron Life Sciences Corp (4KH.BE)July 11, 2023 | msn.comCannabis Stock Gainers And Losers From July 11, 2023June 19, 2023 | sg.finance.yahoo.comKHRNF - Khiron Life Sciences Corp.June 5, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron Life Sciences Agrees to $500,000 Secured DepositJune 5, 2023 | finance.yahoo.comKhiron Life Sciences Agrees to $500,000 Secured DepositMay 6, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDERApril 20, 2023 | finance.yahoo.comKhiron Completes First Phase of Business OptimizationApril 17, 2023 | msn.comKhiron Life Sciences CFO Helen Bellwood to be replaced by Michael O'ConnorApril 17, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES NEW CFOApril 17, 2023 | finance.yahoo.comTake Care Before Jumping Onto Khiron Life Sciences Corp. (CVE:KHRN) Even Though It's 47% CheaperApril 12, 2023 | theglobeandmail.comClosing Bell: Khiron Life Sciences Corp WT down on Monday (KHRN-WT)March 24, 2023 | benzinga.comKhiron Stock Trading Lower On Announcing Pricing Of Marketed Offering Of UnitsMarch 24, 2023 | finance.yahoo.comKHIRON LIFE SCIENCES ANNOUNCES PRICING OF MARKETED OFFERING OF UNITSMarch 16, 2023 | marketwatch.comKhiron Life Sciences Shares Drop 28% on Overnight OfferingFebruary 17, 2023 | seekingalpha.comKHRNF Khiron Life Sciences Corp.February 16, 2023 | finance.yahoo.comKhiron Closes Additional Loan with Investment-Grade BankFebruary 14, 2023 | finance.yahoo.comKhiron Closes Revolving Credit Facility with Financing Company in ColombiaJanuary 18, 2023 | proactiveinvestors.comKhiron Life Sciences shares growth in medical cannabis field throughout South America and EuropeJanuary 9, 2023 | finanznachrichten.deKhiron Life Sciences Corp.: Khiron wins first medical cannabis contract with Colombia's largest public insurance companyDecember 1, 2022 | finance.yahoo.comKhiron Life Sciences Third Quarter 2022 Earnings: CA$0.017 loss per share (vs CA$0.019 loss in 3Q 2021)See More Headlines Receive KHRNF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Khiron Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A Current SymbolOTCMKTS:KHRNF CUSIPN/A CIKN/A Webwww.khiron.ca Phone(702) 527-3564FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report Key ExecutivesDr. Alvaro Francisco Torres (Age 45)Co-Founder, CEO & Director Comp: $200.96kMs. Franziska KatterbachPresident of Khiron EuropeMr. Swapan Kakumanu ACA (Age 54)ACWA, CGA, Corporate Secretary Comp: $44.18kMr. Michael John O'Connor MA (Age 57)Chief Financial Officer Mr. Manuel BuendiaVice President of OperationsMr. Marco AlgortaCountry Manager of UruguayMore ExecutivesKey Competitors1933 IndustriesOTCMKTS:TGIFF4Cable TV InternationalOTCMKTS:CATV4Front VenturesOTCMKTS:FFNTFAB ScienceOTCMKTS:ABSCFAbacus Health ProductsOTCMKTS:ABAHFView All Competitors KHRNF Stock Analysis - Frequently Asked Questions How do I buy shares of Khiron Life Sciences? Shares of KHRNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:KHRNF) was last updated on 5/21/2024 by MarketBeat.com Staff From Our Partners4 Cryptos BETTER than BitcoinTrue Market Insiders[FREE Ticket] 27 Crypto Experts Reveal Their #1 Picks Crypto 101 MediaHe Is Giving Away BitcoinCrypto Swap ProfitsNext President (Not Trump. Not Biden.)The Freeport SocietyThis Apple-like Innovator is Revolutionizing HealthcareWall Street StarWarren Buffett's "mystery stock"Stansberry ResearchThis Could be Your “Big Money” AI MomentInvestorPlaceElon to Transform U.S. Economy? Porter & Company Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Khiron Life Sciences Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.